GSA Capital Partners »

Miragen Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $802k 26k 31.12
2024-12-31 $217k 11k 19.15
2023-09-30 $166k 11k 15.31